Rechargeable bladder device could save money, study hopes
NCT ID NCT07173517
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will compare the costs of two types of sacral neuromodulation devices—rechargeable and non-rechargeable—for treating neurogenic lower urinary tract dysfunction. Researchers will track expenses in 268 patients who have not responded to standard treatments. The goal is to see if the newer rechargeable device is more budget-friendly over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- sacral neuromodulation device (rechargeable vs non-rechargeable)
- What this could lead to
- If rechargeable devices prove cheaper, hospitals may switch to them, potentially lowering long-term costs for patients with bladder control problems.
- What could go wrong
- This is an observational cost study, not a treatment trial. It won't test if the devices work better, only their cost impact. Results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROGENIC LOWER URINARY TRACT DYSFUNCTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Qilu Hospital
Jinan, Shandong, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New wearable device could help people with spinal injuries know when to empty their bladder
- Bladder cocktail aims to stop recurrent UTIs in spinal cord injury
- Could a simple ultrasound replace invasive bladder tests for spinal injury patients?
- Bladder treatment preferences: patients speak out in new study